Dopamides, vanillylamides, ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances as TRPV1 ligands (Q46251262)

20 December 2017

title

Dopamides, vanillylamides, ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances as TRPV1 ligands (English)

1 reference

20 December 2017

0 references

4

1 reference

20 December 2017

Luciano De Petrocellis

3

object named as

Luciano De Petrocellis

1 reference

20 December 2017

author name string

Christian Sinning

1

1 reference

20 December 2017

Bernhard Watzer

2

1 reference

20 December 2017

Peter Imming

5

1 reference

20 December 2017

publication date

1 December 2008

1 reference

20 December 2017

published in

ChemMedChem

1 reference

20 December 2017

volume

3

1 reference

20 December 2017

issue

12

1 reference

20 December 2017

page(s)

1956-1964

1 reference

20 December 2017

The capsaicin receptor: a heat-activated ion channel in the pain pathway

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Biochemistry and pharmacology of endovanilloids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Molecular mechanisms of nociception

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Inhibition of the vanilloid receptor subtype-1 attenuates TNBS-colitis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic "A-region".

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

The responses of rat trigeminal ganglion neurons to capsaicin and two nonpungent vanilloid receptor agonists, olvanil and glyceryl nonamide.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Interaction of the di-catechols rooperol and nordihydroguaiaretic acid with oxidative systems in the human blood. A structure-activity relationship

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Differential effects of putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Activation of inhibition from the periaqueductal grey matter mediates central analgesic effect of metamizol (dipyrone).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Anti-nociception induced by systemic or PAG-microinjected lysine-acetylsalicylate in rats. Effects on tail-flick related activity of medullary off- and on-cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

A study of the mechanism of action of the mild analgesic dipyrone

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800271

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800271

1 reference

20 December 2017

PubMed ID

19003845

1 reference

20 December 2017